Anthropic eyes in-house drug discovery with Claude Science AI platform

TL;DR Summary
Anthropic unveiled Claude Science, an AI workbench for scientists, and signaled plans to develop its own drugs—targeting neglected diseases—while continuing to sell AI tools to biotech and pharma customers. Experts say AI can accelerate drug discovery but human oversight, data gaps, and regulatory hurdles mean any AI-designed drug is likely years away.
- Anthropic wants to develop its own drugs The Verge
- Claude Science, an AI workbench for scientists, is now available Anthropic
- Anthropic releases Claude Science, a product aimed at researchers, the pharma industry STAT
- Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare CNBC
- Anthropic debuts Claude Science, renews access to Fable 5, Mythos 5 MobiHealthNews
Reading Insights
Total Reads
1
Unique Readers
13
Time Saved
6 min
vs 6 min read
Condensed
96%
1,189 → 52 words
Want the full story? Read the original article
Read on The Verge